Mark Leeds, D.O.
Mark Leeds, D.O.
Sublocade Tapering vs Brixadi Tapering: Which is Best for Suboxone Tapering?
Sublocade Tapering vs Brixadi Tapering: Which is Best for Suboxone Tapering?
Sublocade Tapering vs Brixadi Tapering: Which is Best for Suboxone Tapering?
Monday 4th March 2024
Dr. Mark Leeds compares Sublocade and Brixadi for Suboxone tapering, discussing their benefits, side effects, costs, and patient experiences.
11 minutes
Informative
Educational
Supportive
Encouraging
Non-judgmental
About this podcast
Author:
Mark Leeds, D.O.
Overview:
Categories:
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
375 (View all)
Do you want to link to this podcast?
Get the buttons here!Sublocade vs Brixadi: The Best Approach to Suboxone Tapering?
Episode Overview
- Sublocade offers a monthly injection that reduces daily dosing needs.
- Brixadi includes naloxone to help curb cravings and withdrawal symptoms.
- Both medications show promising results but have different benefits.
- Cost and availability are important factors to consider.
- Consult healthcare professionals for personalised guidance.
The choice between Sublocade and Brixadi should be personalised based on individual needs, preferences, and circumstances.
If you're curious about the best methods for tapering off Suboxone, this episode is a must-listen. Dr. Mark Leeds, an osteopathic physician with extensive experience in addiction treatment, dives into the nitty-gritty of Sublocade and Brixadi tapering. These two long-acting buprenorphine injections have been making waves for their effectiveness in helping individuals gradually reduce their dependence on Suboxone, a medication used to treat opioid addiction. But which one is better? That's the million-dollar question Dr. Leeds aims to answer.
Sublocade and Brixadi both offer unique advantages. Sublocade is a monthly injectable form of buprenorphine that provides a sustained release over time, eliminating the need for daily doses and reducing the risk of misuse. On the other hand, Brixadi also offers monthly injections but includes naloxone to further curb cravings and withdrawal symptoms. Both medications have shown promising results in clinical studies, but there are nuances worth noting. Dr.
Leeds discusses how these medications work, their side effects, and their costs. Sublocade tends to be more expensive but offers steady blood levels of buprenorphine, making it a reliable option for many. Brixadi, being newer, offers more flexibility with both weekly and monthly dosing options and doesn't require cold storage, which can be a game-changer for some patients. Patient experiences also play a crucial role in this discussion.
Reviews suggest that both medications are well-received, with many patients appreciating the convenience of monthly injections and reporting fewer cravings and withdrawal symptoms. So, what's the verdict? Dr. Leeds emphasises that the choice between Sublocade and Brixadi should be personalised based on individual needs, preferences, and circumstances. Consulting with healthcare professionals can provide the tailored guidance needed to make an informed decision. Ready to explore which tapering method might be right for you?
Tune in to this enlightening episode and take a step closer to your recovery journey.